Home› Library› Protocol› Semax
Semax reconstitution protocol
Reconstitution of Semax, the ACTH(4-7)-derived nootropic peptide studied predominantly in Russian neuroscience literature.
RECONSTITUTION & RESEARCH PROTOCOLS
Emerging clinical evidenceResearch protocol intensities, summarized from published literature. The math is computed for the vial size you pick. Not a dosing recommendation.
Approved in Russia for ischemic stroke and cognitive indications. Western literature limited; most research from Russian neuroscience groups.
Reference research protocols from published peer-reviewed studies. Each card cites its source. This calculator is not a dosing recommendation. For research use only. Selection of any specific protocol is the responsibility of the qualified investigator under appropriate institutional oversight.
This protocol describes the reconstitution and storage of lyophilized Semax in standard research workflows. Semax is a synthetic 7-amino-acid peptide derived from ACTH (4–7) extended with a Pro-Gly-Pro tail. It's studied predominantly for nootropic and neuroprotective effects in Russian neuroscience literature. Values below reflect published handling literature; study design is the responsibility of the qualified investigator.
At a glance
| Parameter | Value |
|---|---|
| Recommended diluent | Bacteriostatic Water (USP, 0.9% benzyl alcohol) |
| Recommended volume (10 mg vial) | 2.0 mL |
| Final concentration | 5 mg/mL |
| Stability — lyophilized | ≥24 months at -20 °C, sealed, light-protected |
| Stability — reconstituted | 30 days at 2–8 °C in original vial |
| Routes studied | Intranasal (most common in Russian literature), subcutaneous, intraperitoneal |
Procedure
- Equilibrate the vial to room temperature.
- Sterile prep: wipe stopper with isopropyl. Use sterile syringe and needle.
- Inject diluent slowly along the inner wall.
- Swirl gently. Dissolution completes within 30 seconds.
- Verify: solution should be clear and colorless.
Compound notes
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is the 4–7 fragment of adrenocorticotropic hormone (ACTH) with a Pro-Gly-Pro C-terminal extension. The ACTH fragment is responsible for the cognitive effects observed in older literature; the Pro-Gly-Pro extension increases enzymatic stability so the peptide survives administration long enough to act centrally.
Most published research focuses on:
- Neuroprotection in stroke models (the original Russian clinical indication)
- Cognitive enhancement in rodent learning and memory tasks
- BDNF and NGF upregulation in CNS tissue
- Attention and stress-response modulation
The intranasal route is unusually well-characterized for Semax — it bypasses first-pass metabolism and allows direct nose-to-brain transfer through the cribriform plate. For research models studying central effects, intranasal administration produces measurable CSF concentrations within minutes; subcutaneous administration produces lower CSF exposure due to limited blood-brain barrier penetration.
The peptide is well-behaved in standard buffers and tolerant of typical ionic strength variation. Plasma half-life is short (~15–30 minutes); CNS effects persist longer due to the receptor-binding kinetics rather than the pharmacokinetic profile.
Storage
Reconstituted Semax is stable for approximately 30 days at 2–8 °C. For longer storage, aliquot into sterile single-use tubes and freeze at -20 °C or colder. Lyophilized stability is ≥24 months at -20 °C light-protected.
Notes
This protocol describes reconstitution parameters from published handling literature. It is not a recommendation for any specific research protocol or design. For research use only. Not for human consumption.
References
- Asmarin IP, Nezavibatko VN, Levitskaya NG, et al. Nootropic and analgesic activity of semax: the heptapeptide [Met-Glu-His-Phe-Pro-Gly-Pro]. Patol Fiziol Eksp Ter 1997;1:11–17. PMID: 9221920
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem 2006;97 Suppl 1:82–86. PMID: 16635253
Was this helpful?
We reply to every research inquiry.